Company intelligence / Profile preview
Drug Farm
United Statesmygnp.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Drug Farm has advanced multiple first-in-class drug candidates into clinical development using its proprietary IDInVivo platform. Lead candidate DF‑006, an orally administered ALPK1 agonist immunomodulator targeting innate immunity in the liver, has completed single/multiple ascending dose studies in healthy volunteers and chronic hepatitis B patients with encouraging anti-HBV activity observed. Another candidate, DF‑003 targeting ALPK1 for ROSAH syndrome and related disorders, has completed Phase 1 safety studies.
- Therapeutic areas
- Rare DiseasesInfectious DiseasesOphthalmologyGastroenterologyOncologyNephrologyCardiovascular
- Modalities
- Small moleculeMonoclonal antibodyImmunomodulatorAgonist
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →03
Partnerships
Amoytop/Xiamen Amoytop Biotech Co., Ltd.National Institutes of Health
Beyond the preview
Go deeper on Drug Farm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Drug Farm.